3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
7
Small Cell Lung Carcinoma
6
Fallopian Tube Neoplasms
4
Lung Neoplasms
3
Sarcoma, Ewing
2
Neoplasm Metastasis
2
Ganglioneuroblastoma
2
Uterine Cervical Neoplasms
1
SCLC
1
Rhabdoid Tumor
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Interventions
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Cytarabine
3
venetoclax
2
ponatinib
2
merphos
2
fludarabine phosphate
2
Tacrolimus
2
Idarubicin
2
Etoposide
2
Cyclosporine
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
midostaurin
1
gilteritinib
1
blinatumomab
1
Thiotepa
1
Sirolimus
1
Razoxane
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Melphalan
1
Injections
1
Gemtuzumab
1
Dexrazoxane
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
Topotecan
×
30 days
×
Clear all
No trials found.